Frequently Asked Questions

A Creative Commons licence is a standard, publicly available framework that lets authors and organisations grant the public permission to use their work while retaining certain rights as the copyright holder. It makes sharing and reusing creative and scholarly content simple and legally clear. There are six common variants — CC BY, CC BY-SA, CC BY-NC, CC BY-NC-SA, CC BY-ND, and CC BY-NC-ND. Full details on each licence are available at creativecommons.org.

All journals on Research Platform publish articles under the CC BY 4.0 licence. This allows anyone to freely share, remix, adapt, and build upon the published content in any format — including for commercial purposes — provided appropriate credit is given to the original author(s).

Article Processing Charges vary by journal and are published transparently on each journal's page. The inaugural issue of any new journal is typically published free of charge. All articles remain freely and permanently accessible under open access, which broadens dissemination and improves the visibility and citation potential of your work.

All submissions are handled through our dedicated online manuscript submission and tracking platform. Using this system ensures efficient handling, accurate status tracking, and avoids the delays associated with email-based submissions.

Research Platform primarily uses a single-blind review process, where reviewer identities remain confidential while author identities are visible to reviewers. Some journals may operate double-blind or open review models — the applicable model is stated in each journal's editorial policy.

Since all articles are published under the CC BY 4.0 licence, no formal permission is required to reproduce any portion of an article. You must, however, provide appropriate attribution by citing the original source in full.

We follow the ICMJE (International Committee of Medical Journal Editors) guidelines on authorship. Only individuals who meet the ICMJE criteria for authorship should be listed; other contributors should be acknowledged separately.

To propose a new journal title, please contact our editorial office by email (see Contact Us below). Include the proposed journal name, its aims and scope, a suggested list of editors, and any other relevant supporting information.

Requests for corrections or retractions should be directed to the editorial office of the relevant journal. Please include clear reasons and supporting documentation; the editorial office will guide you through the review process.

We welcome new reviewers to register through our reviewer registration process. Your profile will be evaluated by the relevant journal editor, and if it matches the journal's requirements, you will be invited to review suitable manuscripts.

The average review period is typically 3–4 weeks from the date of first submission, though this can vary by journal and subject area.

Yes. Please notify the editorial office as soon as possible, and they will assess whether an extension can be granted based on the journal's publication timeline.

Please do not proceed with the review. Contact the editorial office immediately so an alternative, unconflicted reviewer can be assigned to ensure an unbiased evaluation.

No — please do not contact the author directly regarding plagiarism concerns. Instead, notify the editorial office promptly so they can investigate and take appropriate action in line with our publication ethics policy.

If you're interested in joining an editorial board, please select a journal and role of interest and submit your request through our editorial board application process. Your profile will be reviewed, and a decision will be communicated to you by the editorial office.

The editorial board shapes journal content, selects qualified reviewers, and makes final editorial decisions. Their oversight ensures that published articles meet the scholarly standards and scope defined for each journal.